Researchers continue to debate whether US president Abraham Lincoln was coming down with smallpox as he delivered his famous Gettysburg Address, and if he had been immunized.
The Scientist Creative Services Team | Oct 22, 2020
TRACKMAN® Connected is a tablet with accessories and apps that makes pipetting faster and more verifiable, which improves reliability, traceability, and reproducibility at the bench.
Preliminary data suggest that the newly dubbed Omicron variant may be more infectious than previous versions of the virus, but it will take time to obtain the reliable data needed to answer pressing questions about its biology.
Epidemiological research suggests that a flu diagnosis might be one factor in the eventual onset of the neurodegenerative disease, but experts say it doesn’t prove a causal relationship.
Researchers used sequencing data and phenotypic traits to predict which of 5,400 species were most likely to be susceptible to contracting and spreading the virus back to humans.
The Scientist Creative Services Team | Oct 6, 2020
In this webinar brought to you by MMI, learn how scientists use CellScan for a variety of lab applications, such as routine photo-documentation, whole-slide scanning, fluorescence imaging, time-resolved live-cell imaging, and combinations of these techniques.
Pharoah’s work ended endemic cretinism in a remote region of Papua New Guinea and contributed to the understanding of myriad other perinatal health conditions.
In response to two November 2021 articles in The Scientist that called out preprints as a source of medical misinformation, the cofounders of bioRxiv and medRxiv say it’s not the publishing model that’s at fault.
The Scientist Creative Services Team | Sep 24, 2020
Download this eBook to discover how genomic sequencing is uncovering new information about the SARS-CoV-2 virus and aiding public health decision making in the fight against a global pandemic!
While the weather isn’t currently the dominant factor driving SARS-CoV-2 transmission, experts say that in the future COVID-19 may become a disease of winter.
Cancer cells develop resistance to targeted therapies, and their inherent functional heterogeneity makes it difficult for researchers to understand and characterize these resistance mechanisms. IsoPlexis' single-cell proteomics is helping researchers overcome resistance to targeted inhibitors, leading to better strategies and combination therapies.
Authors of a newly published study on the use of an antidepressant for COVID-19 claim the drug greatly reduces hospitalizations and mortality. But some experts question whether that’s really what the data show.
Preprints are likely here to stay. The press, the public, and the research community must adapt to this relatively recent model of scientific publishing if we are to extract its benefits while avoiding its pitfalls.
